PROMOTION OF N-NITROSODIMETHYLAMINE-INITIATED MOUSE LUNG-TUMORS FOLLOWING SINGLE OR MULTIPLE LOW-DOSE EXPOSURE TO 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN

被引:21
作者
BEEBE, LE
ANVER, MR
RIGGS, CW
FORNWALD, LW
ANDERSON, LM
机构
[1] NCI, FREDERICK CANC RES & DEV CTR, PRI DYNCORP, PATHOL HISTOTECHNOL LAB, FREDERICK, MD 21702 USA
[2] NCI, FREDERICK CANC RES & DEV CTR, DATA MANAGEMENT SERV INC, FREDERICK, MD 21702 USA
[3] NCI, FREDERICK CANC RES & DEV CTR, PRI DYNCORP, BIOL CARCINOGENESIS & DEV PROGRAM, FREDERICK, MD 21702 USA
关键词
D O I
10.1093/carcin/16.6.1345
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The environmental contaminant, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), is highly toxic to several rodent species and may have adverse health effects in exposed human populations. Further, TCDD has been shown to be a potent liver tumor promoter in the rat after repeated administration. These studies were conducted to determine the tumor promoting capability of TCDD in the Swiss mouse following single or multiple exposures. Following tumor initiation with N-nitrosodimethylamine (NDMA; 25 mg/kg), animals were given either a single dose (1.6, 16 or 48 mu g/kg) or repeated injections (0.05 mu g/kg/week for 20 weeks) of TCDD and sacrificed at 52 weeks of age. Neither NDMA nor TCDD caused an increase in incidence of liver tumors. NDMA induced lung tumors in 100% of animals, with 12 +/- 0.1 tumors/mouse. The multiplicity of lung tumors was significantly increased by low dose TCDD treatment, with 20 +/- 2.6 tumors/mouse following a single 1.6 mu g/kg dose (P = 0.016) and 18 +/- 1.7 (P = 0.031) following repeated 0.05 mu g/kg doses (x20). Higher doses of TCDD did not increase multiplicity of lung tumors and, in fact, may have been toxic to the lungs of NDMA-treated mice, as evidenced by the infiltration of pigmented macrophages. These data demonstrate the potent tumor promoting capability of TCDD in mouse lung.
引用
收藏
页码:1345 / 1349
页数:5
相关论文
共 26 条
  • [1] Eisler R., Polychlorinated biphenyls hazards to fish wildlife and invertebrates: A synoptic review, US Fish. Wildl. Serv. Biol. Rep., 85, pp. 1-72, (1986)
  • [2] Johnson E.S., Human exposure to 2, 3, 7, 8-TCDD and risk of cancer, CRC Cril. Rex. Toxicol., 21, pp. 451-463, (1992)
  • [3] Couture-Haws L., Harris M.W., Lockhart A.C., Bimbaum L.S., Evaluation of the persistence of hydronephrosis induced in mice following in utero and/or lactational exposure to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin, Toxicol. Appl. Pharmacol., 107, pp. 402-412, (1991)
  • [4] Matusumura F., Biochemical aspects of action mechanisms of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD) and related chemicals in animals, Pharmacol. Ther., 19, pp. 195-209, (1983)
  • [5] Geiger L.E., Neal R.A., Mutagenicity testing of 23, 7, 8- tetrachlorodibenzo-p-dioxin in histidine auxotrophs of Salmonella typhimurium, Toxicol. Appl. Pharmacol., 59, pp. 125-129, (1981)
  • [6] Kociba R.J., Results of a two-year chronic toxicity and oncogenicity study of 2, 3, 7, 8-letrachlorodibenzo-p-dioxin in rats, Toxicol. Appl. Pharmacol., 46, pp. 279-303, (1978)
  • [7] Carcinogenesis Bioassay of 23, 7, 8- Elrachlorodibenzo-P-Dioxin (CAS# 1746-01-6) in Osbome-Mendel Rats and B6C3F1 Mice (Gavage Study), (1982)
  • [8] Pitot H.C., Goldsworthy T., Campbell H.A., Poland A., Quantitative evaluation of the promotion by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin of hepatocarcinogenesis from diethylnitrosamine, Cancer Res., 40, pp. 3616-3620, (1980)
  • [9] Abemethy D.J., Greenlee W.F., Huband J.C., Boreiko C.J., Tetrachlorodibenzo-β-dioxin (TCDD) promotes the transformation of C3H/I0T1/2 cells, Carcinogenesis, 6, pp. 651-653, (1985)
  • [10] Beebe L., Park S.S., Anderson L.M., Differentia] enzyme induction in mouse liver and lung following a single low or high dose of 23, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD), J. Biochem. Toxicol., 5, pp. 211-219, (1990)